What is the appropriate management for a postoperative patient with decompensated heart failure, mild diastolic dysfunction on transthoracic echocardiogram, and an ejection fraction of 67%?

Management of Postoperative Decompensated Heart Failure with Preserved Ejection Fraction

Initiate intravenous loop diuretics immediately without delay to relieve congestion, as this patient has heart failure with preserved ejection fraction (HFpEF) presenting with acute decompensation in the postoperative setting 1.

Immediate Acute Management

Diuretic Therapy (First-Line)

• Start IV loop diuretics (furosemide) immediately - therapy should begin without delay as early intervention improves outcomes 1
• If the patient was already on oral diuretics, the initial IV dose should equal or exceed their chronic oral daily dose 1
• Monitor urine output and titrate the dose upward to relieve symptoms and reduce fluid overload 1
• If inadequate diuresis occurs, intensify using:
  • Higher doses of loop diuretics
  • Addition of a second diuretic (metolazone, spironolactone, or IV chlorothiazide)
  • Continuous infusion of loop diuretic 1

Vasodilator Therapy (Adjunctive)

• If blood pressure is adequate (no symptomatic hypotension), consider adding IV nitroglycerin, nitroprusside, or nesiritide to diuretics for relief of dyspnea 2
• Critical caveat: Patients with HFpEF are typically more volume-sensitive, so use vasodilators cautiously 2
• These agents do NOT improve mortality or rehospitalization - they are purely for symptom relief 2

Monitoring Requirements

• Daily measurements: fluid intake/output, vital signs (supine and standing), body weight at same time each day 1
• Daily labs during IV diuretic use: electrolytes, BUN, creatinine 1
• Monitor for supine and upright hypotension, worsening renal function, and HF symptoms 1

Postoperative-Specific Considerations

Identify and Treat Precipitating Factors

The postoperative state creates unique triggers that must be addressed 1:

• Acute coronary syndrome/ischemia - obtain ECG and troponin
• Severe hypertension - common trigger in diastolic dysfunction
• Atrial fibrillation or other arrhythmias - particularly problematic in HFpEF
• Infections
• Pulmonary emboli
• Renal failure
• Fluid overload from perioperative IV fluids

Hemodynamic Management Principles for Diastolic Dysfunction

This patient's mild diastolic dysfunction with preserved EF (67%) requires specific attention 3, 4:

• Maintain adequate preload - these patients are preload-dependent
• Avoid tachycardia - diastolic filling time is critical
• Control hypertension - keep pulse pressure below diastolic blood pressure 4
• Maintain sinus rhythm - atrial contribution to ventricular filling is essential
• Avoid excessive diuresis - can precipitate hypotension and end-organ hypoperfusion

When to Consider Invasive Monitoring

Use invasive hemodynamic monitoring (pulmonary artery catheter) if 1:

• Respiratory distress or impaired perfusion where filling pressures cannot be determined clinically
• Fluid status, perfusion, or vascular resistance uncertain
• Persistent symptoms despite empiric therapy adjustments
• Worsening renal function with therapy

Avoid Common Pitfalls

Do NOT use inotropes unless there is documented severe systolic dysfunction with hypoperfusion and low cardiac output - this patient has normal EF 1. Inotropes in normotensive patients without decreased organ perfusion are contraindicated 1.

Do NOT aggressively diurese to "dry weight" - patients with diastolic dysfunction tolerate hypovolemia poorly and may develop hypotension and renal dysfunction 3, 4.

Do NOT overlook atrial fibrillation - loss of atrial kick can precipitate acute decompensation in diastolic dysfunction 4.

Transition to Discharge

Once stabilized 1:

• Transition from IV to oral diuretics with careful attention to dosing
• Monitor for orthostatic hypotension and worsening renal function during transition 1
• Provide comprehensive written discharge instructions covering: diet (sodium restriction), medications, activity level, follow-up appointments, daily weights, and what to do if symptoms worsen 1
• Initiate or continue SGLT2 inhibitor if not contraindicated - strongest evidence for reducing HF hospitalizations in HFpEF 5, 6

VTE Prophylaxis

Administer venous thromboembolism prophylaxis with anticoagulation if risk-benefit ratio is favorable - HF patients are at increased risk, especially when hospitalized 2.